Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. 2019

Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Vascular contributions to cognitive impairment are increasingly recognized1-5 as shown by neuropathological6,7, neuroimaging4,8-11, and cerebrospinal fluid biomarker4,12 studies. Moreover, small vessel disease of the brain has been estimated to contribute to approximately 50% of all dementias worldwide, including those caused by Alzheimer's disease (AD)3,4,13. Vascular changes in AD have been typically attributed to the vasoactive and/or vasculotoxic effects of amyloid-β (Aβ)3,11,14, and more recently tau15. Animal studies suggest that Aβ and tau lead to blood vessel abnormalities and blood-brain barrier (BBB) breakdown14-16. Although neurovascular dysfunction3,11 and BBB breakdown develop early in AD1,4,5,8-10,12,13, how they relate to changes in the AD classical biomarkers Aβ and tau, which also develop before dementia17, remains unknown. To address this question, we studied brain capillary damage using a novel cerebrospinal fluid biomarker of BBB-associated capillary mural cell pericyte, soluble platelet-derived growth factor receptor-β8,18, and regional BBB permeability using dynamic contrast-enhanced magnetic resonance imaging8-10. Our data show that individuals with early cognitive dysfunction develop brain capillary damage and BBB breakdown in the hippocampus irrespective of Alzheimer's Aβ and/or tau biomarker changes, suggesting that BBB breakdown is an early biomarker of human cognitive dysfunction independent of Aβ and tau.

UI MeSH Term Description Entries
D001812 Blood-Brain Barrier Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue. Brain-Blood Barrier,Hemato-Encephalic Barrier,Barrier, Blood-Brain,Barrier, Brain-Blood,Barrier, Hemato-Encephalic,Barriers, Blood-Brain,Barriers, Brain-Blood,Barriers, Hemato-Encephalic,Blood Brain Barrier,Blood-Brain Barriers,Brain Blood Barrier,Brain-Blood Barriers,Hemato Encephalic Barrier,Hemato-Encephalic Barriers
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments
D020797 Receptor, Platelet-Derived Growth Factor beta A PDGF receptor that binds specifically to the PDGF-B chain. It contains a protein-tyrosine kinase activity that is involved in SIGNAL TRANSDUCTION. Antigens, CD140b,CD140b Antigens,PDGF beta Receptor,PDGFR beta,Platelet-Derived Growth Factor beta Receptor,Receptor, PDGF beta,CD140b Antigen,PDGFR1,PDGFRB,Antigen, CD140b,Platelet Derived Growth Factor beta Receptor,Receptor, Platelet Derived Growth Factor beta,beta, PDGFR
D021621 Imaging, Three-Dimensional The process of generating three-dimensional images by electronic, photographic, or other methods. For example, three-dimensional images can be generated by assembling multiple tomographic images with the aid of a computer, while photographic 3-D images (HOLOGRAPHY) can be made by exposing film to the interference pattern created when two laser light sources shine on an object. Computer-Assisted Three-Dimensional Imaging,Imaging, Three-Dimensional, Computer Assisted,3-D Image,3-D Imaging,Computer-Generated 3D Imaging,Three-Dimensional Image,Three-Dimensional Imaging, Computer Generated,3 D Image,3 D Imaging,3-D Images,3-D Imagings,3D Imaging, Computer-Generated,3D Imagings, Computer-Generated,Computer Assisted Three Dimensional Imaging,Computer Generated 3D Imaging,Computer-Assisted Three-Dimensional Imagings,Computer-Generated 3D Imagings,Image, 3-D,Image, Three-Dimensional,Images, 3-D,Images, Three-Dimensional,Imaging, 3-D,Imaging, Computer-Assisted Three-Dimensional,Imaging, Computer-Generated 3D,Imaging, Three Dimensional,Imagings, 3-D,Imagings, Computer-Assisted Three-Dimensional,Imagings, Computer-Generated 3D,Imagings, Three-Dimensional,Three Dimensional Image,Three Dimensional Imaging, Computer Generated,Three-Dimensional Images,Three-Dimensional Imaging,Three-Dimensional Imaging, Computer-Assisted,Three-Dimensional Imagings,Three-Dimensional Imagings, Computer-Assisted

Related Publications

Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
January 2021, Frontiers in neuroscience,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
October 2023, Neurology and therapy,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
October 2019, Journal of neurosurgery,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
December 2018, Alzheimer's & dementia : the journal of the Alzheimer's Association,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
January 2015, Neuron,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
January 2003, Methods in molecular medicine,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
January 1991, Neuroradiology,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
June 2017, Brain : a journal of neurology,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
December 2016, Clinical rheumatology,
Daniel A Nation, and Melanie D Sweeney, and Axel Montagne, and Abhay P Sagare, and Lina M D'Orazio, and Maricarmen Pachicano, and Farshid Sepehrband, and Amy R Nelson, and David P Buennagel, and Michael G Harrington, and Tammie L S Benzinger, and Anne M Fagan, and John M Ringman, and Lon S Schneider, and John C Morris, and Helena C Chui, and Meng Law, and Arthur W Toga, and Berislav V Zlokovic
January 2017, Current neurovascular research,
Copied contents to your clipboard!